Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - ENRIGHT PATRICK G
Last Updated 
8-Jul-15
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

ENRIGHT PATRICK G: Declared Holdings
Company/RelationshipReportedShares  Ownership
Corcept Therapeutics Incorporat
Director
NasdaqCM:CORT
(historical quotes, profile, other insiders)
30-Mar-1514,711,890  Indirect
Esperion Therapeutics, Inc.
Director
NasdaqGM:ESPR
(historical quotes, profile, other insiders)
19-Mar-15934,396  Indirect
Jazz Pharmaceuticals plc
Director
NasdaqGS:JAZZ
(historical quotes, profile, other insiders)
12-Dec-14
6-Jul-15
1,650
   290,000
291,650
  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
6-Jul-15 *10,000JAZZ Sale at $175.81 - $178.59 per share.
(Proceeds of about $1,772,000)
1-Jun-15 *10,000JAZZ Sale at $177.82 - $179.43 per share.
(Proceeds of about $1,786,000)
11-May-15 *10,000JAZZ Sale at $175.98 - $176.64 per share.
(Proceeds of about $1,763,000)
6-Apr-15 *10,000JAZZ Sale at $168.31 - $169.97 per share.
(Proceeds of about $1,691,000)
30-Mar-15 *856,644CORT Option Exercise at $4.05 per share.
(Cost of $3,469,408)
24-Mar-15 *554,348CORT Sale at $5.65 per share.
(Proceeds of $3,132,066)
24-Mar-15 *1,130,709CORT Option Exercise at $2.77 per share.
(Cost of $3,132,063)
20-Mar-15 *1,130,709CORT Option Exercise at $2.77 per share.
(Cost of $3,132,063)
20-Mar-15 *535,397CORT Sale at $5.85 per share.
(Proceeds of $3,132,072)
19-Mar-15 *500,000ESPR Sale at $110.01 - $116.05 per share.
(Proceeds of about $56,515,000)
2-Mar-15 *10,000JAZZ Sale at $172.60 - $177.51 per share.
(Proceeds of about $1,751,000)
10-Feb-15 *10,000JAZZ Sale at $166.45 - $168.14 per share.
(Proceeds of about $1,673,000)
5-Jan-15 *10,000JAZZ Sale at $159.68 - $161.57 per share.
(Proceeds of about $1,606,000)
12-Dec-14 2,343JAZZ Sale at $170.32 - $172.53 per share.
(Proceeds of about $402,000)
1-Dec-14 *10,000JAZZ Sale at $170.96 - $177.1 per share.
(Proceeds of about $1,740,000)
18-Nov-14 *5,104ESPR Sale at $31.56 - $32.14 per share.
(Proceeds of about $163,000)
17-Nov-14 *482,026ESPR Sale at $32.01 - $33.79 per share.
(Proceeds of about $15,859,000)
10-Nov-14 *10,000JAZZ Sale at $170.90 - $171.71 per share.
(Proceeds of about $1,713,000)
9-Oct-14 *943ESPR Sale at $30 per share.
(Proceeds of $28,290)
7-Oct-14 *11,927ESPR Sale at $30.04 per share.
(Proceeds of $358,287)
6-Oct-14 *10,000JAZZ Sale at $159.47 - $161.57 per share.
(Proceeds of about $1,605,000)
2-Sep-14 *10,000JAZZ Sale at $162.71 - $163.89 per share.
(Proceeds of about $1,633,000)
12-Aug-14 1,087JAZZ Sale at $133.15 per share.
(Proceeds of $144,734)
7-Aug-14 1,650JAZZ Acquisition (Non Open Market) at $0 per share.
2-May-14 *86,443CORT Sale at $4.07 per share.
(Proceeds of $351,823)
1-May-14 *163,557CORT Sale at $4.12 per share.
(Proceeds of $673,854)
1-Apr-14 *250,000CORT Sale at $4.28 per share.
(Proceeds of $1,070,000)
7-Mar-14 *10,430CORT Sale at $4 per share.
(Proceeds of $41,720)
6-Mar-14 *168,103CORT Sale at $4 per share.
(Proceeds of $672,412)
5-Mar-14 *71,467CORT Sale at $4.01 per share.
(Proceeds of $286,582)
3-Mar-14 *11,761JAZZ Sale at $147.87 - $153.8 per share.
(Proceeds of about $1,774,000)
28-Feb-14 *547,867JAZZ Sale at $150.50 - $165.94 per share.
(Proceeds of about $86,684,000)
28-Feb-14 *947,867JAZZ Option Exercise at $4 per share.
(Cost of $3,791,468)
13-Aug-13 1,070JAZZ Sale at $81.86 per share.
(Proceeds of $87,590)
8-Aug-13 2,250JAZZ Acquisition (Non Open Market) at $0 per share.
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?